Andrew Allen is the founder of Gritstone Oncology. Gritstone Oncology has raised $157M in total funding. Latest round: Series A.
Andrew Allen is the Co-Founder, President, and CEO of Gritstone bio (formerly Gritstone Oncology), a clinical-stage biotech company developing immunotherapies for cancers and infectious diseases. He leads the company's efforts in creating personalized cancer vaccines and has been instrumental in securing major funding.
Full founder directory · Investor directory · Company funding database · Fundraising library